Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
June 1, 1981
A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension
G Muiesan, E Agabiti-Rosei, R Buoninconti, et al.
Giornale Italiano Di Cardiologia
|
January 1, 1980
[A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)]
G Muiesan, E Agabiti-Rosei, R Buoninconti, et al.
Journal of Cardiovascular Pharmacology
|
February 24, 1999
Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group
G Maschio, D Alberti, F Locatelli, et al.
Journal of Neurochemistry
|
October 27, 2006
Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid
R Verani, I Cappuccio, P Spinsanti, et al.
American Heart Journal
|
August 1, 1990
Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study
C Tantucci, B Bruni, M L Dottorini, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimen
G Muiesan, E Agabiti-Rosei, A Carotti, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus
L Epifano, A Di Vincenzo, C Fanelli, et al.
Kidney International. Supplement
|
January 4, 1998
Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group
F Locatelli, I R Carbarns, G Maschio, et al.
Therapeutic Drug Monitoring
|
March 1, 1991
Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patients
J B Lecaillon, J P Dubois, T Darragon, et al.
Diabete & Metabolisme
|
July 1, 1992
Short-term metabolic effects of the ACE-inhibitor benazepril in type 2 diabetes mellitus associated with arterial hypertension
P De Feo, E Torlone, G Perriello, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
June 1, 1981
A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension
G Muiesan, E Agabiti-Rosei, R Buoninconti, et al.
Giornale Italiano Di Cardiologia
|
January 1, 1980
[A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)]
G Muiesan, E Agabiti-Rosei, R Buoninconti, et al.
Journal of Cardiovascular Pharmacology
|
February 24, 1999
Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group
G Maschio, D Alberti, F Locatelli, et al.
Journal of Neurochemistry
|
October 27, 2006
Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid
R Verani, I Cappuccio, P Spinsanti, et al.
American Heart Journal
|
August 1, 1990
Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study
C Tantucci, B Bruni, M L Dottorini, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimen
G Muiesan, E Agabiti-Rosei, A Carotti, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus
L Epifano, A Di Vincenzo, C Fanelli, et al.
Kidney International. Supplement
|
January 4, 1998
Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group
F Locatelli, I R Carbarns, G Maschio, et al.
Therapeutic Drug Monitoring
|
March 1, 1991
Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patients
J B Lecaillon, J P Dubois, T Darragon, et al.
Diabete & Metabolisme
|
July 1, 1992
Short-term metabolic effects of the ACE-inhibitor benazepril in type 2 diabetes mellitus associated with arterial hypertension
P De Feo, E Torlone, G Perriello, et al.
Page
of 8